Back to search

Boston University

Investigating the impact of IL-17A signaling in osteoclasts and osteoblasts on bone loss in spondyloarthritis and estrogen deficiency

Abstract

dc:description.abstract

INTRODUCTION: Diverging bone phenotypes have been described in spondylarthritis. Both pathogenic new bone formation and bone loss are observed which may be explained by pleiotropic effects of IL-17A. Studies in mice have yielded contradictory results regarding the effect of IL-17A signaling in osteoclasts and osteoblasts. As IL-17A signals through a receptor composed of IL-17RA and IL-17RC chains, we sought to elucidate the bone phenotypes caused by IL-17A-mediated inflammation in mice with cell-type specific conditional deletion of the Il17rc gene. METHODS: Il17rcf/f mice were crossed with Cathepsin K-cre (Ctsk-cre) and Prx1-cre driver mice to abrogate IL-17A signaling in osteoclasts and mesenchymal cells, respectively. Baseline studies were conducted in 12-week-old male and female Il17rcf/f, Il17rcf/f.Ctsk-cre and Il17rcf/f.Prx1-cre mice. A second cohort of female mice underwent ovariectomy (OVX) or sham surgery at 12 weeks of age with analysis 8 weeks post OVX. A third cohort of male mice was hydrodynamically injected with IL-23 minicircles at 8 weeks of age. Animals were weighed weekly and analyzed after 4 weeks. For each cohort, cortical and trabecular bone parameters were measured by micro-CT. Serum was harvested for analysis of CTX-1, P1NP and IL-17A by ELISA. In a separate experiment, osteoclast precursors in the bone marrow were quantified by flow cytometry 2 weeks after OVX. RESULTS: There were no baseline differences in trabecular or cortical bone parameters, CTX-1, P1NP, or IL-17A serum concentrations between Il17rcf/f, Il17rcf/f.Ctsk-cre and Il17rcf/f.Prx1-cre mice. In contrast, OVX-induced bone loss was partially abrogated in Ctsk-cre mice (Figure 1), without significant differences in IL-17A, CTX-1 or P1NP serum concentrations between genotypes. The frequency of osteoclast precursors decreased after OVX compared with sham, without significant differences between Il17rcf/f and Il17rcf/f.Ctk-cre mice. Significant trabecular bone loss was observed in response to IL-23 minicircle injection. However, there were no significant differences in bone parameters between Il17rcf/f, Il17rcf/f.Ctsk-cre and Il17rcf/f.Prx1-cre mice overexpressing IL-23. CONCLUSIONS: Mice with conditional deletion of Il17rc in osteoclasts or mesenchymal cells, respectively, had phenotypically normal bones at baseline. Il17rc deletion in osteoclasts (Ctsk-cre mice) partially abrogated the bone loss induced by OVX. In contrast, bone loss due to IL-23 overexpression appeared to be independent of IL-17A signaling in osteoclasts or osteoblasts.

Degree

thesis:*
Name thesis:degree_name
Master of Science
Level thesis:degree_level
masters
Discipline thesis:degree_discipline
Medical Sciences
Grantor
Boston University
Year dc:date.issued
2023

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Martorana, Makayla
Advisors dc:contributor.advisor
  • Ermann, Joerg
  • Wisco, Jonathan

Subjects

dc:subject × 1

Rights

Language dc:language.iso
en_US

Identifiers

dc:identifier.*
Handle dc:identifier.uri
https://hdl.handle.net/2144/48301

Chain of custody

source
Harvested from
Boston University
Base URL
open.bu.edu/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Martorana, Makayla. Investigating the impact of IL-17A signaling in osteoclasts and osteoblasts on bone loss in spondyloarthritis and estrogen deficiency. masters thesis, Boston University, 2023. https://hdl.handle.net/2144/48301